EUVIMEDEUVIMED entdecken
Open Access

RNA sensing induced by chromosome missegregation augments anti-tumor immunity

Nobunari Sasaki, Mizuki Homme, Takahiko Murayama, Tatsuya Osaki, Toshiyuki Tenma, Tadaichi An, Yujiro Takegami, Tetsuo Tani, Patrick C Gedeon, Yoshihisa Kobayashi, Israel Cañadas, David A Barbie und 2 weitere

Molecular Cell · 2025-02 · 85 (4) · 770-786.e7

DOI: 10.1016/j.molcel.2024.11.025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cell, 2025-02. Verfasst von Nobunari Sasaki und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Cancer Institute, Japanese Foundation for Cancer Research, Koto-ku, Tokyo 135-8550, Japan. Hauptthemen laut MEDLINE: RNA, Double-Stranded, Neoplasms, Micronuclei, Chromosome-Defective. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, Kobayashi Foundation for Cancer Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Viral mimicry driven by endogenous double-stranded RNA (dsRNA) stimulates innate and adaptive immune responses. However, the mechanisms that regulate dsRNA-forming transcripts during cancer therapy remain unclear. Here, we demonstrate that dsRNA is significantly accumulated in cancer cells following pharmacologic induction of micronuclei, stimulating mitochondrial antiviral signaling (MAVS)-mediated dsRNA sensing in conjunction with the cyclic GMP-AMP synthase (cGAS)/stimulator of interferon genes (STING) pathway. Activation of cytosolic dsRNA sensing cooperates with double-stranded DNA (dsDNA) sensing to upregulate immune cell migration and antigen-presenting machinery. Tracing of dsRNA-sequences reveals that dsRNA-forming transcripts are predominantly generated from non-exonic regions, particularly in locations proximal to genes exhibiting high chromatin accessibility. Activation of this pathway by pulsed monopolar spindle 1 (MPS1) inhibitor treatment, which potently induces micronuclei formation, upregulates cytoplasmic dsRNA sensing and thus promotes anti-tumor immunity mediated by cytotoxic lymphocyte activation in vivo. Collectively, our findings uncover a mechanism in which dsRNA sensing cooperates with dsDNA sensing to boost immune responses, offering an approach to enhance the efficacy of cancer therapies targeting genomic instability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Double-StrandedNeoplasmsMicronuclei, Chromosome-DefectiveHumansAnimalsNucleotidyltransferasesCell Line, TumorMiceMembrane ProteinsCell Cycle ProteinsMice, Inbred C57BLAdaptor Proteins, Signal TransducingSignal TransductionImmunity, InnateLymphocyte ActivationGenomic InstabilitySTING ProteinCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Stichwörter der Autor:innen

MAVSMps1STINGcGASchromosome missegregationdsRNAmicronucleitumor immunitytype I interferon

Substanzen

RNA, Double-StrandedNucleotidyltransferasesMembrane ProteinsCell Cycle ProteinsAdaptor Proteins, Signal TransducingSTING1 protein, humanSTING ProteincGAS protein, humanCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Autor:innen und Institutionen

  • Department of Cell Biology, Cancer Institute, Japanese Foundation for Cancer Research, Koto-ku, Tokyo 135-8550, Japan.
  • Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
  • Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Institute of Industrial Science, The University of Tokyo, Meguro-ku, Tokyo 153-8505, Japan.
  • Respiratory Center, Asahikawa Medical University Hospital, Asahikawa 078-8510, Japan.
  • DNAFORM Precision Gene Technologies, Yokohama, Kanagawa 230-0051, Japan.
  • Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • Kobayashi Foundation for Cancer Research
  • Princess Takamatsu Cancer Research Fund
  • Japan Science and Technology Agency
  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • Takeda Science Foundation

Zitieren

APA

Sasaki, N., Homme, M., Murayama, T., Osaki, T., Tenma, T., An, T., Takegami, Y., Tani, T., Gedeon, P. C., Kobayashi, Y., Cañadas, I., Barbie, D. A., Yao, R., & Kitajima, S. (2025). RNA sensing induced by chromosome missegregation augments anti-tumor immunity. Molecular Cell, 85(4), 770-786.e7. https://doi.org/10.1016/j.molcel.2024.11.025

Vancouver

Sasaki N, Homme M, Murayama T, Osaki T, Tenma T, An T, et al. RNA sensing induced by chromosome missegregation augments anti-tumor immunity. Molecular Cell. 2025;85(4):770-786.e7. doi:10.1016/j.molcel.2024.11.025

BibTeX
@article{Sasaki2025,
  author = {Sasaki, Nobunari and Homme, Mizuki and Murayama, Takahiko and Osaki, Tatsuya and Tenma, Toshiyuki and An, Tadaichi and Takegami, Yujiro and Tani, Tetsuo and Gedeon, Patrick C and Kobayashi, Yoshihisa and Cañadas, Israel and Barbie, David A and Yao, Ryoji and Kitajima, Shunsuke},
  title = {RNA sensing induced by chromosome missegregation augments anti-tumor immunity},
  journal = {Molecular Cell},
  year = {2025},
  volume = {85},
  number = {4},
  pages = {770--786.e7},
  doi = {10.1016/j.molcel.2024.11.025}
}
Kostenlos starten →